Title : From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.

Pub. Date : 2021 Jan 25

PMID : 33504092






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These studies on angiotensin II led to the discovery of Sarmesin, a type II angiotensin II antagonist, and the breakthrough non-peptide mimetic Losartan, the first in a series of sartans marketed as a new generation of anti-hypertensive drugs in the 1990s. Losartan angiotensinogen Homo sapiens